ERBB2 and breast cancer: In addition, we found increased levels of S100A8 and S100A9 in TNBC and HER2-positive BC subtypes compared to Luminal-A and Luminal-B breast tumor subgroups, respectively, and we also highlight a strong correlation between S100A8 and S100A9 gene expression levels in TNBC.